News and Trends 9 Dec 2022
The Native Antigen Company expands infectious disease portfolio
The Native Antigen Company (part of LGC Clinical Diagnostics), today announced the commercial release of its Sudan Ebolavirus Boniface 1976…
Liza Laws
Articles by Liza Laws
News and Trends 8 Dec 2022
PDC*line Pharma presents first immunological results from trial with PDC*lung01
PDC*line Pharma, a clinical stage biotech company has announced the first immunological results of its PDC-LUNG-101 phase 1/2 clinical trial…
More News! 8 Dec 2022
Enhertu’s positive results demonstrate improvement in overall survival
Enhertu, an antibody drug conjugate, being jointly developed by Daiichi Sankyo and AstraZeneca, has demonstrated a statistically significant and clinically…
News and Trends 8 Dec 2022
Metrion and KCNC1 Foundation announce collaboration to identify therapeutic
Metrion Biosciences Limited, and The KCNC1 Foundation are to collaborate to try and find a therapeutic for children. The KCNC1…
ADVERTISEMENT
News and Trends 8 Dec 2022
Polyplus announces completion of acquisition of Xpress Biologics to expand plasmid DNA
Polyplus has announced the completion of an acquisition of Belgian Xpress Biologics to expand plasmid DNA technology. Xpress Biologics specializes…
News and Trends 7 Dec 2022
Ibex and Source announce agreement to aid pathologists with diagnostic accuracy
An agreement has been announced between Ibex Medical Analytics and Source LDPath, part of Source BioScience. It will expand the…
News and Trends 7 Dec 2022
Neuraxpharm’s expansion into the Netherlands takes it from two to 20 countries in six years
Neuraxpharm Group, a European pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, has announced the establishment…
News and Trends 7 Dec 2022
Owlstone Medical launches Breath Biopsy AOC Atlas built with diverse breath samples
Owlstone Medical, a U.K. company working in breath biopsy for applications in early disease detection and precision medicine has announced…
News and Trends 6 Dec 2022
Tetra announce significant results from the study of Onternabez combined with Favipiravir
Tetra Bio-Pharma Inc. a leader in cannabinoid-derived drug discovery and development announced today significant results from the study of Onternabez…
News and Trends 6 Dec 2022
Pictor receives $5M in funding for Covid antibody test and human and animal portfolios
Pictor, a global leader in immunodiagnostics, has announced a $5 million funding round to help accelerate pipeline product development projects.…
ADVERTISEMENT
News and Trends 6 Dec 2022
Startup Graegis developing therapies for radiation side-effects
Graegis Pharmaceuticals, a startup developing new therapies aimed at preventing the side effects of radiotherapies, is set to complete the…
News and Trends 5 Dec 2022
Positive antibody persistence for vaccine treating mosquito disease
A single shot vaccine for mosquito-borne disease chikungunya has had positive antibody persistence data 12 months after vaccination. The primary…
News and Trends 5 Dec 2022
Fallouh Healthcare’s device to give early diagnosis for post-surgery strangulation risk
U.K.-based Fallouh Healthcare is developing a device to monitor cardiac patients after surgery, which is when a condition, called cardiac…
Interview 5 Dec 2022
Interview: why the recently approved fecal microbiome product is causing a rumble
The news last week of the FDA approving Ferring Pharmaceuticals' first fecal microbiome product, Rebyota, caused quite a stir in…
News and Trends 2 Dec 2022
Tris Pharma and Pediatrix Therapeutics extend partnership for ADHD portfolio
Tris Pharma, Inc announced today (December 2) that they have expanded their partnership allowing Pediatrix Therapeutics to receive exclusive rights to commercialize…
News and Trends 2 Dec 2022
Khondrion’s sonlicromanol produces encouraging results for next stage of study
Biopharma company, Khondrion, has marked announced improvements from patients with MELAS spectrum disorders taking its lead asset, sonlicromanol. Updates were…
ADVERTISEMENT
News and Trends 1 Dec 2022
FDA’s approval of first fecal microbiota product, Rebyota, hailed an ‘enormous step forward’ for the field
The first fecal microbiota product, Rebyota, approved by the U.S. Food and Drug Administration (FDA) today has been hailed ‘fantastic…
News and Trends 1 Dec 2022
FDA clears SparingVision’s investigational new drug application to treat ocular diseases
SparingVision today announces that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND) for…
News and Trends 1 Dec 2022
Trial for HPV16 positive oropharyngeal cancer completes enrolment for phase 2
Netherlands-based ISA Pharmaceuticals B.V., has announced that it has completed enrolment in its phase 2 clinical trial. Named OpcemISA. The…
More News! 30 Nov 2022
FDA grants Sensorion Orphan Drug Designation for hearing loss drug
Sensorion a clinical-stage biotechnology company has announced that the US Food and Drug Administration (FDA) has granted orphan drug designation…